Analysts: Abbott Laboratories (ABT)

ABT on New York Consolidated

42.75USD
29 Jul 2014
Price Change (% chg)

$-0.18 (-0.42%)
Prev Close
$42.93
Open
$42.97
Day's High
$42.98
Day's Low
$42.55
Volume
4,575,268
Avg. Vol
5,537,697
52-wk High
$43.27
52-wk Low
$32.70

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.59 December 30 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 10 10 10 8
(3) HOLD 8 8 8 11
(4) UNDERPERFORM 1 1 1 1
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.32 2.32 2.32 2.42

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 13 5,636.27 5,746.00 5,477.00 5,780.53
Quarter Ending Dec-14 9 5,994.44 6,102.00 5,774.00 6,194.52
Year Ending Dec-14 11 22,465.40 22,844.00 22,045.00 23,391.80
Year Ending Dec-15 12 23,661.80 24,084.20 22,883.00 24,868.90
Earnings (per share)
Quarter Ending Sep-14 15 0.59 0.61 0.49 0.56
Quarter Ending Dec-14 11 0.69 0.75 0.55 0.66
Year Ending Dec-14 13 2.23 2.28 2.00 2.23
Year Ending Dec-15 13 2.47 2.60 2.21 2.49
LT Growth Rate (%) 6 10.33 13.00 8.00 11.47

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 5,522.47 5,551.00 28.53 0.52
Quarter Ending Mar-14 5,273.89 5,244.00 29.89 0.57
Quarter Ending Dec-13 5,717.10 5,655.00 62.10 1.09
Quarter Ending Sep-13 5,394.42 5,369.00 25.42 0.47
Quarter Ending Jun-13 5,519.38 5,446.00 73.38 1.33
Earnings (per share)
Quarter Ending Jun-14 0.51 0.54 0.03 6.68
Quarter Ending Mar-14 0.36 0.41 0.05 15.07
Quarter Ending Dec-13 0.58 0.58 0.00 0.34
Quarter Ending Sep-13 0.51 0.55 0.04 7.17
Quarter Ending Jun-13 0.44 0.46 0.02 4.21

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 5,636.27 5,636.25 5,634.24 5,634.18 5,780.53
Quarter Ending Dec-14 5,994.44 5,996.19 6,017.52 6,017.39 6,194.52
Year Ending Dec-14 22,465.40 22,493.20 22,463.60 22,471.10 23,391.80
Year Ending Dec-15 23,661.80 23,661.80 23,685.30 23,724.00 24,868.90
Earnings (per share)
Quarter Ending Sep-14 0.59 0.59 0.60 0.60 0.56
Quarter Ending Dec-14 0.69 0.69 0.68 0.68 0.66
Year Ending Dec-14 2.23 2.22 2.19 2.19 2.23
Year Ending Dec-15 2.47 2.47 2.45 2.46 2.49

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 4 5
Quarter Ending Dec-14 0 0 5 3
Year Ending Dec-14 0 0 5 4
Year Ending Dec-15 0 0 5 4
Earnings
Quarter Ending Sep-14 0 0 3 4
Quarter Ending Dec-14 0 0 8 2
Year Ending Dec-14 1 0 11 0
Year Ending Dec-15 0 0 8 1

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks